CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive®, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC), is pleased to announce two upcoming webcast programs on multiple sclerosis (MS) in October.
“Our partnership with CMSC is leading to extremely important education for neurology professionals everywhere,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of NeurologyLive®. “Through these programs, attendees will get expert perspectives on hot topics in MS that will lead to improved patient care and outcomes.”
The October programs from NeurologyLive® and CMSC will feature the following interactive virtual webcasts:
- Differing Perspectives on Multiple Sclerosis Care: Nursing and Patient Program will be a two-part webcast series geared toward MS nursing professionals and patients. The first session for MS nursing professionals will take place on Saturday, Oct. 10, from 9 a.m. to noon EDT, followed by a complimentary patient program from 12:30 to 2:30 p.m. EDT. The featured speakers are Denise Bruen, ANP-BC, MSN, MSCN; Stephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCN; and Marie Namey, APRN, MSCN. This innovative program will provide nurses and patients with evidence-based information on the latest disease-modifying therapies, as well as symptoms and the psychological impact of MS, in order to educate and improve the relationships between MS nursing professionals and their patients. Nursing professionals will earn three CE credits for completing the nursing program. To register, click here.
- Cannabis and MS: Helping Patients Understand Risks and Benefits, a three-part webcast series, will take place on Wednesdays, Oct. 14, 21 and 28, at 7 p.m. EDT. The featured speaker is Allen C. Bowling, M.D., Ph.D., director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado. During this progressive three-part series, Bowling will describe the current understanding of pharmacology, efficacy and adverse events associated with cannabis use in MS, including drug interactions, the role of the Food and Drug Administration and MS clinical trial data, among other topics. Participants will earn one CE credit for completing each session. To register, click here.
“The partnership between the CMSC and NeurologyLive continues to bring the best in accredited education in MS to the healthcare community,” said CMSC CEO June Halper, MSN, APN-C, MSCN, FAAN.
A multimedia platform for health care professionals treating neurological diseases, NeurologyLive® delivers direct access to practice-changing news and expert insights directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke. The NeurologyLive® platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive® platform also connects visitors with the most up-to-date clinical trial results, FDA approvals, practice-changing research and expert insights. NeurologyLive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
About Consortium of Multiple Sclerosis Centers (CMSC)
The Consortium of Multiple Sclerosis Centers (CMSC) is the largest North American multidisciplinary membership organization dedicated to defining and advancing the standard of care of MS patients. Its mission is to promote high-quality MS care through education, training, clinical research, networking and targeted advocacy efforts.
The CMSC includes a professional network of 13,500 health care clinicians and scientists worldwide. The membership represents the full spectrum of MS health care professionals: physicians, nursing professionals, advanced practice clinicians, pharmacists, rehabilitation and mental health professionals, researchers and patient advocates. The work of the CMSC directly influences the quality of care for hundreds of thousands of people living with MS.